Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025

Core Insights - Vivani Medical, Inc. is a clinical-stage biopharmaceutical company focused on developing miniature, ultra long-acting drug implants aimed at improving medication adherence and patient tolerance [1][4]. Group 1: Company Presentation - CEO Adam Mendelsohn, Ph.D., will present at the ThinkEquity Conference on October 30, 2025, at 1:30 p.m. Eastern Time in New York [1][2]. - The presentation will be available via webcast on Vivani's corporate website [2]. Group 2: Company Overview - Vivani utilizes its proprietary NanoPortal™ platform to create biopharmaceutical implants that deliver drug molecules steadily over extended periods [4]. - The company is developing a portfolio of GLP-1 based implants targeting metabolic diseases such as obesity and type 2 diabetes [4]. - Medication non-adherence affects approximately 50% of patients, including those on daily pills, highlighting the need for innovative delivery methods [4].